 "Cell therapy solution for bone joint disorders")
Mumbai-based Regrow Biosciences has developed a cell therapy-based solution to address issues pertaining to the orthopaedic joint.
The company is now looking at raising funds from private equity entities and angel investors to scale up its operations. It has also applied for clinical trials in the European Union and America, with plans to start an office in the US within a year.
Pharmaceutical distributor Yash Sanghavi has bootstrapped his start-up, which has developed products Ossgrow (to treat early-stage avascular necrosis of the hip joint) and Catrigrow (treating cartilage loss in the knees or early stage osteoarthritis) at his laboratory in Lonavala, near
